SCHEMBL21396722

SCHEMBL21396722

N#Cc1cccc(-n2c3ccccc3c3ccccc32)c1-c1cccc(-c2cccnc2-n2c3ccccc3c3ccccc32)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 1/20 0.35
GABRA1 P14867 6/20 0.35
GABRG2 P18507 6/20 0.35
GABRB3 P28472 6/20 0.35
GABRA2 P47869 4/20 0.35
GABRA5 P31644 4/20 0.35
GABRA3 P34903 4/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
HIF1A Q16665 1/20 0.34
DRD2 P14416 4/20 0.34
HTR2A P28223 3/20 0.34
KDM4E B2RXH2 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
HPGD P15428 2/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21396768 0.89 DRD2 (0.38) SMN1; SMN2HIF1ADRD2HTR2AKDM4E
SCHEMBL21397049 0.85 GABRA1 (0.36) USP30GABRA1GABRG2GABRB3GABRA2
SCHEMBL21396716 0.85 KDM4E (0.37) SMN1; SMN2HIF1AKDM4EMEN1LMNA
SCHEMBL21396680 0.84 CYP11B2 (0.40) KDM4ECYP1A2CYP3A4HPGDMEN1
SCHEMBL22378618 0.84 SMN1; SMN2 (0.44) USP30GABRA1GABRG2GABRB3GABRA2
SCHEMBL21396746 0.83 SMN1; SMN2 (0.35) SMN1; SMN2HIF1ADRD2HTR2AKDM4E
SCHEMBL21396961 0.83 GRM5 (0.35) GABRA1GABRG2GABRB3GABRA3DRD2
SCHEMBL21396723 0.81 NCOA3 (0.37) USP30GABRA1GABRG2GABRB3GABRA2
SCHEMBL21396732 0.81 USP30 (0.40) USP30GABRA1GABRG2GABRB3GABRA2
SCHEMBL22327522 0.80 SMN1; SMN2 (0.36) GABRA1GABRG2GABRB3GABRA2GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190296247-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190296247-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SLC25A21, SLCO4C1, SLC18A1 USP30 3777/4885GABRA1 2479/4885GABRG2 3243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.